Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Carcinoma, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00568438
What this trial is testing

Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

Who this might be right for
Breast CancerStomach NeoplasmsSalivary Gland Neoplasms+1 more
Stanford University 169
Early research (Phase 1)Study completedNCT04134884
What this trial is testing

Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerTriple Negative Breast CancerHormone Receptor Positive Tumor
Kathy Miller 34
Large-scale testing (Phase 3)Active Not RecruitingNCT04862663
What this trial is testing

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 893
Early research (Phase 1)Study completedNCT01730118
What this trial is testing

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Who this might be right for
Breast NeoplasmsBreast CancerAdenocarcinomas+1 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Looking for participantsNCT05556473
What this trial is testing

F-Tryptophan PET/CT in Human Cancers

Who this might be right for
Intracranial GliomaMetastatic Brain TumorBreast Cancer+2 more
Barbara Ann Karmanos Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT03901339
What this trial is testing

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 543
Early research (Phase 1)Study completedNCT05923177
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Looking for participantsNCT06666270
What this trial is testing

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid CancerMetastatic Solid TumorOvarian Cancer+4 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd 30
Early research (Phase 1)Study completedNCT04277338
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 30
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Very early researchStudy completedNCT03004534
What this trial is testing

Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Who this might be right for
Breast Cancer Female
Translational Research in Oncology 36
Very early researchStudy completedNCT04130152
What this trial is testing

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 22
Testing effectiveness (Phase 2)Study completedNCT00509769
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 112
Testing effectiveness (Phase 2)Study completedNCT02536339
What this trial is testing

Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06369831
What this trial is testing

HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011

Who this might be right for
Metastatic Breast CancerMetastatic Solid Cancer
Abscint NV/SA 60
Early research (Phase 1)Study completedNCT04568902
What this trial is testing

Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 33
Early research (Phase 1)Study completedNCT01432886
What this trial is testing

Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer

Who this might be right for
Breast Cancer
Eisai Co., Ltd. 12
Not applicableStudy completedNCT02393924
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study

Who this might be right for
Breast Cancer
Hoffmann-La Roche 311
Not applicableStudy completedNCT05695859
What this trial is testing

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 24
Testing effectiveness (Phase 2)Study completedNCT01269346
What this trial is testing

Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Eisai Inc. 52
Next Page